title: [Candidate patient for subcutaneous apomorphine injection].
abstract: Subcutaneous apomorphine injection is a fast-action, effective treatment option, that enables many patients to be rescued from predictable and non-predictable off episodes. It is an easy-to-use technique after minimum training. The neurologist can use it on patients with advanced Parkinson's disease only by following some basic procedures which are easily implemented in outpatient setting.
authors.affiliation: Hospital Infanta Luisa, Sevilla, Espana.
authors.forename: José R
authors.initials: JR
authors.lastname: Chacón
authors.forename: Marina
authors.initials: M
authors.lastname: Mata
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001058:Apomorphine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007279:Injections, Subcutaneous; D007774:Lactation; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D018579:Patient Selection; D011247:Pregnancy; D011248:Pregnancy Complications; D011605:Psychoses, Substance-Induced / Q000209:etiology
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007980:Levodopa; D001058:Apomorphine